abstract |
SUMMARY OF THE INVENTION The disclosed invention provides pharmaceutical compositions for treating inflammatory conditions, particularly those conditions characterized by increased binding of α-9 integrin to one or more of its ligands. Things and methods. Also disclosed are methods for selecting compounds for use in such compositions and methods. |